Oryzon Genomics SA (ORY) — Strategic Asset Allocation Index
Oryzon Genomics SA (ORY) has a Strategic Asset Allocation Index of 0.7% as of June 2023. Strategic assets (PP&E of €545.97K plus long-term investments of €-) total €545.97K, measured against net assets of €78.54 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Oryzon Genomics SA Strategic Asset Allocation Index (2011–2022)
This chart shows how Oryzon Genomics SA's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 0.7%, representing strategic assets of €545.97K against net assets of €78.54 Million EUR. Explore Oryzon Genomics SA (ORY) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Oryzon Genomics SA (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Oryzon Genomics SA from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ORY company net worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.8% | €611.42K | €611.42K | €- | €72.57 Million | ▼ -0.1 pp |
| 2021 | 1.0% | €682.42K | €682.42K | €- | €71.26 Million | ▲ +0.1 pp |
| 2020 | 0.8% | €643.92K | €643.92K | €- | €75.93 Million | ▲ +0.0 pp |
| 2019 | 0.8% | €672.08K | €631.28K | €40.80K | €80.02 Million | ▼ -0.7 pp |
| 2018 | 1.6% | €705.71K | €664.91K | €40.80K | €45.13 Million | ▼ -0.4 pp |
| 2017 | 2.0% | €679.28K | €638.28K | €41.00K | €34.43 Million | ▼ -1.3 pp |
| 2016 | 3.2% | €736.87K | €695.87K | €41.00K | €22.73 Million | ▼ -1.1 pp |
| 2015 | 4.3% | €1.20 Million | €853.56K | €344.29K | €27.59 Million | ▼ -6.4 pp |
| 2014 | 10.7% | €1.49 Million | €981.00K | €505.57K | €13.89 Million | ▼ -2.9 pp |
| 2013 | 13.6% | €2.00 Million | €1.16 Million | €844.78K | €14.73 Million | ▲ +4.6 pp |
| 2012 | 9.0% | €1.49 Million | €1.49 Million | €- | €16.43 Million | ▼ -1.2 pp |
| 2011 | 10.2% | €1.71 Million | €1.71 Million | €- | €16.76 Million | — |